Aggrenox [aspirin/dipyridamole] Prevention of Access Stenosis (IND 64,202)

Trial Profile

Aggrenox [aspirin/dipyridamole] Prevention of Access Stenosis (IND 64,202)

Phase of Trial: Phase III

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Aspirin/dipyridamole (Primary)
  • Indications Embolism and thrombosis; Vascular graft occlusion
  • Focus Therapeutic Use
  • Acronyms Graft
  • Most Recent Events

    • 21 May 2009 Results published in the New England Journal of Medicine.
    • 30 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top